Citadel Advisors »

Biomarin Pharma Inc convertible/ shares owned by Citadel Advisors

Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Biomarin Pharma Inc convertible/

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharma Inc convertible/ held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharma Inc convertible/ by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.9M 4.0M 0.99

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Biomarin Pharma Inc convertible/

OZ Management
Millennium Management
Citigroup
Aviva
Two Sigma Investments
Calamos Advisors
Partner Fund Management
Bank of America Corporation
Lord, Abbett & Co
Sunrise Partners Limited Partnership
Centiva Capital
Jpmorgan Chase & Co
RWC Asset Management
MacKay Shields
Palisade Capital Management

View all funds holding Biomarin Pharma Inc convertible/